Text Size A A A

Sun Pharma In The News

Tell a Friend Print Home » Media » Sun Pharma In The News

Sun arm gets FDA nod for antidepressant drug

Sun Pharmaceutical Industries Ltd said its subsidiary has received approval from the US Food and Drug Administration (FDA) to market the bupropion hydrochloride antidepressants tablets, the company said in a filing to the Bombay Stock Exchange. The bupropion hydrochloride extended-release tablets are used for the treatment of major depressive disorders.